Cancer Trials
Omar Abdihamid/LinkedIn

Evaluating Phase III Cancer Trials Against CSO Principles – Common Sense Oncology

Common Sense Oncology shared a post on LinkedIn:

“Congratulations to former CSO Fellow Dr. Omar Abdihamid (first author) and collaborators for publishing a paper in the European Journal of Cancer evaluating 55 randomized clinical trials for adherence to the CSO’s principles for phase III cancer RCTs published earlier this year in The Lancet Oncology.

Read more about CSO principles for RCTs.”

Title: Adherence of published randomised Phase 3 cancer trials to principles proposed by common-sense oncology

Authors: Omar Abdihamid, Bishal Gyawali, Christopher M. Booth, Elizabeth A. Eisenhauer, Wilma M. Hopman, Brian Shkabari, Dario Trapani, Haydee C. Verduzco-Aguirre, Brooke E. Wilson, Ian F. Tannock

Read the Full Article.

Evaluating Phase III Cancer Trials Against CSO Principles - Common Sense Oncology

More posts featuring Common Sense Oncology.